Synthetic dipeptide bioregulator · Fact sheet
Vilon
Also known as Lys-Glu · KE peptide
Vilon is a synthetic Lys-Glu dipeptide studied in mouse aging and cell-culture experiments. Chromatin or immune-marker changes do not establish human immune rejuvenation or lifespan extension.
What is Vilon?
Vilon is a defined dipeptide, distinct from a thymus tissue extract.
Experiments on cultured lymphocytes from older people are human-cell studies, not trials showing that treated people become healthier.
Benefits & claims
Interest centers on immune and digestive biology, aging and cellular function. Biological activity does not itself establish a clinical treatment.
What the evidence supports
- One mouse study reported lifespan and physical-activity changes.
- Cultured lymphocyte studies reported changes in chromatin organization and gene activity.
- Those cellular changes do not establish fewer infections, reduced cancer risk or longer human life.
Research areas
- Experimental tissue and cellular responses
- Formulation-specific outcomes
Dosage & frequency
No established human regimenThe reviewed sources do not establish a human treatment amount or frequency for Vilon. Animal and laboratory exposures are not human regimens.
How to read these amounts
An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.
Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences
Formulations, interactions & practical context
- Identity and pharmacology
- Vilon is a defined dipeptide, distinct from a thymus tissue extract.
Formulation differences
- Experiments on cultured lymphocytes from older people are human-cell studies, not trials showing that treated people become healthier.
Interactions & precautions
- The reviewed sources do not establish a comprehensive human interaction profile for this exact substance or combination.
What is still unresolved
- Controlled human clinical outcomes for the exact substance
- Human exposure, pharmacokinetics and repeated-use safety
- Independent replication and formulation equivalence
Side effects & risks
- Human immune effects, long-term toxicity and interactions remain insufficiently characterized.
- Changing gene activity is not inherently beneficial and needs tissue- and outcome-specific evaluation.
This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.
Clinical research
Mostly animal or lab researchThe cited evidence concerns mice and cultured cells. A mouse lifespan finding does not establish a human longevity treatment.
Studies
Female-mouse lifespan and physiologic study.
Cultured lymphocyte chromatin study.
Cultured thymic-cell differentiation study.
Personal experiences
Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.
No attributable personal accounts were found in the sources reviewed.
Approval status
Vilon has no FDA-approved therapeutic product. The cited experiments or cosmetic uses do not establish an approved human treatment.
Preclinical evidence; no FDA-approved product
Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.
Open questions
- Controlled human clinical outcomes for the exact substance
- Human exposure, pharmacokinetics and repeated-use safety
- Independent replication and formulation equivalence
Summary
Those cellular changes do not establish fewer infections, reduced cancer risk or longer human life.
Sources
Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.
- pubmedEffect of vilon on biological age and lifespan in mice.
Female-mouse lifespan and physiologic study.
- pubmedBioregulator Vilon-induced reactivation of chromatin in cultured lymphocytes from old people.
Cultured lymphocyte chromatin study.
- pubmedImmunomodulating effects of Vilon and its analogue in the culture of human and animal thymus cells.
Cultured thymic-cell differentiation study.